Bradley Messmer

Abreos Biosciences develops lateral flow assays that measure the activity of high-value biologics. Its simple devices can be used for quality assurance, pharmacokinetic monitoring, and authentication in field, forensic, or point of care settings. We deliver value by enhancing brand protection, improving patients’ outcomes, and enabling rapidauthentication for counterfeit prevention and end-user confidence. The company was founded in 2013 and headquartered in San Diego, California.